1 Min Read
Feb 21 (Reuters) - NOVO NORDISK:
* SAYS ITS GLP-1 DRUG OZEMPIC HAS BEEN INCLUDED IN U.S. EXPRESS SCRIPT 2018 FORMULARY LIST FURTHER COMPANY COVERAGE: (Reporting by Jacob Gronholt-Pedersen)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.